209 results
8-K
EX-99.1
RGEN
Repligen Corp.
19 Mar 24
Repligen Appoints Maggie A. Pax to Board of Directors
7:41am
Scientific, where, from 2016–2020, she served as Vice President, Strategy and Innovation for the clinical supply chain business. In this role, she … &A integration. We look forward to her involvement and input.”
In addition to her role as Vice President Strategy and Innovation at Thermo Fisher, Ms. Pax’s
8-K
EX-99.1
RGEN
Repligen Corp.
2 Oct 23
Repligen Appoints Olivier Loeillot As President and Chief Commercial Officer
7:42am
key account strategy and expanding the market impact of Repligen’s business units in bioprocessing, while collaborating with the company’s executive
8-K
EX-99.2
ueqa4jawemr608hmy2
26 Sep 23
Repligen Announces Agreement to Acquire
7:44am
8-K
EX-99.1
l82h1vu05l 86aoco52z
2 Aug 23
Repligen Reports Second Quarter 2023 Financial Results
7:54am
8-K
EX-99.1
nsri1
2 May 23
Repligen Reports First Quarter 2023 Financial Results
7:48am
8-K
EX-99.1
908lu3wzsahrq9gjrey9
12 Apr 23
Regulation FD Disclosure
7:31am
8-K
EX-99.1
ktydr
1 Nov 22
Repligen Reports Third Quarter 2022 Financial Results
7:54am
8-K
EX-10.1
q199lef
1 Jun 22
Repligen Appoints Dr. Konstantin Konstantinov to Board of Directors
5:25pm
8-K
EX-99.1
vdb7wdkbd
27 Apr 22
Repligen Reports First Quarter 2022 Financial Results
7:47am